ARTICLE | Company News
HaptoGuard, University of Calgary deal
May 15, 2006 7:00 AM UTC
The university granted HaptoGuard exclusive worldwide rights to a family of glutathione peroxidase mimetics to treat cardiovascular and other inflammatory diseases. HaptoGuard is being acquired by Al...